Heart Failure Clinical Trial Operations During the COVID-19 Pandemic
The coronavirus disease 2019 (COVID-19) pandemic has led to widespread disruption in the delivery of health care with a significant
Read moreThe coronavirus disease 2019 (COVID-19) pandemic has led to widespread disruption in the delivery of health care with a significant
Read moreBackground: Longitudinal bleeding risk scores have been validated in patients treated with dual antiplatelet therapy (DAPT) following percutaneous coronary intervention.
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/9″>Volume 13, Issue 9</a>, September 1, 2020. Source link
Read moreBackground: Current guidelines recommend aggressive management of hypertension. Recent evidence suggested potential harm with low blood pressure targets in patients
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/9″>Volume 13, Issue 9</a>, September 1, 2020. Source link
Read moreJason L. Vassy Veterans Affairs Boston Healthcare System, MA (Y.-L.H., J.L.V., D.P., J.H., L.C., D.R.G., K.C.). Department of Medicine, Harvard
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/9″>Volume 13, Issue 9</a>, September 1, 2020. Source link
Read moreHelge H. Rasmussen Correspondence to: Helge H. Rasmussen, MD, DMSc, Department of Cardiology, Royal N Shore Hospital, St Leonards, NSW
Read moreCirculation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/13/9″>Volume 13, Issue 9</a>, September 1, 2020. Source link
Read moreZachary M. Gertz Correspondence to: Zachary M. Gertz, MD, VCU Pauley Heart Center, 1200 E Broad St, Box 980036, Richmond,
Read more